Portfolio News.

Latest announcements from holdings.

Portfolio company announcements

Portfolio
ENSIEnSilica

FY26 results due 5 October

Year ended 31 May 2026.

Investor presentation: 13 October, 11:00 BST.

MoreLess · ENSI FY26 results due 5 October

Notice of Results and Investor Presentation
· 07:00

Reporting period
Year ended 31 May 2026.
Results date
5 October 2026.
Presentation
Investor Meet Company, 13 October 2026 at 11:00 BST.
Presenters
CEO Ian Lankshear and CFO Kristoff Rademan.
Shareholder action
Advance questions by 09:00 BST on 12 October, or during the event.
Financial update
Not disclosed.
IGPIntercede

All 12 AGM resolutions passed

H1 trading update scheduled for 8 October 2026.

MoreLess · IGP All 12 AGM resolutions passed

Result of AGM and Notice of Trading Update
· 14:00

Meeting
AGM held 24 September 2026; all 12 resolutions passed.
Support
Votes in favour ranged from 99.63% to 99.98%.
Next update
8 October 2026, covering six months to 30 September 2026.
Financial update
Not disclosed.
Shareholder action
AGM completed; no further action specified in this announcement.
SPRSpringfield Properties

AGM set for 28 October

13:00 in Elgin. Voting instructions in the original notice.

MoreLess · SPR AGM set for 28 October

Notice of AGM
· 07:00

Meeting
28 October 2026 at 13:00.
Venue
Alexander Fleming House, 8 Southfield Drive, Elgin, Morayshire IV30 6GR.
Shareholder action
Consult the company’s notice for resolutions and voting instructions.
Proxy deadline
Not given in this announcement; see the notice of meeting.
Financial update
Not disclosed.
IGPIntercede

Dan O’Brien buys 22,070 shares

Dan O’Brien, non-executive director. Bought 22,070 shares at 120p on 22 September.

Holding after purchase: 75,714 shares / 0.124%.

MoreLess · IGP Dan O’Brien buys 22,070 shares

Director/PDMR Shareholding
· 07:00

Person / role
Dan O’Brien, Non-executive Director.
Transaction / shares / price
Purchase of 22,070 shares at £1.20 on 22 September 2026.
Gross value
£26,484 before costs.Calculated
Resulting interest
75,714 shares; 0.124% of voting rights.
TRTTransense Technologies

FY26 results

Year ended 30 June 2026; comparatives FY25.

Group revenue
£4.626mFY25 £5.550m · includes £0.400m grants
Adj. EBITDA
£0.66mFY25 £1.96m
Cash / net cash
£1.50m / £0.57mNet cash after asset finance · 30 Jun 26

iTrack royalties £2.04m, −34%. SAWsense £1.33m, +20%. Translogik £1.26m, −5%.

What changed

FY27: management targets >25% revenue growth. First two months in line.

MoreLess · TRT FY26 results

Final Results
· 07:00

Period
Year ended 30 June 2026; comparatives FY25.
Revenue
£4.626m / £5.550m; includes grants £0.400m / £0.388m.
Divisions
SAWsense £1.33m (+20%); Translogik £1.26m (−5%); iTrack £2.04m (−34%).
Profitability
Gross margin 88.1% / 89.9%; adjusted EBITDA £0.66m / £1.96m; adjusted PBT £0.02m.
Statutory results
PBT −£0.105m / +£1.408m; EPS −0.69p / +9.25p.
Cash flows
Operating £0.88m / £2.05m; investment £1.28m / £2.09m; asset-finance draw £0.97m.
Liquidity
Cash £1.50m / £1.14m; net cash after asset finance £0.57m / £1.14m.
Dividend / order book
No dividend; order book not quantified.
FY27 target
Revenue growth above 25%; first two months in line.
SPRSpringfield Properties

35,000 shares bought back

35,000 shares at 112.5p on 18 September.

Treasury shares: 70,000. Voting rights: 119,444,287.

MoreLess · SPR 35,000 shares bought back

Transaction in Own Shares
· 14:56

Transaction
35,000 shares on 18 September 2026.
Price
112.5p: highest, lowest and volume-weighted average.
Gross cost
£39,375 before fees.Calculated
Capital
119,514,287 issued; 70,000 treasury; 119,444,287 voting rights.
Cumulative programme
70,000 shares repurchased and held in treasury.
SPRSpringfield Properties

35,000 shares bought back

35,000 shares at 112.5p on 17 September.

Treasury shares: 35,000. Voting rights: 119,479,287.

MoreLess · SPR 35,000 shares bought back

Transaction in Own Shares
· 14:52

Transaction
35,000 shares on 17 September 2026.
Price
112.5p: highest, lowest and volume-weighted average.
Gross cost
£39,375 before fees.Calculated
Capital
119,514,287 issued; 35,000 treasury; 119,479,287 voting rights.
Cumulative programme
35,000 shares repurchased and held in treasury.
SPRSpringfield Properties

Works agreement signed for 39 homes

39 homes. First works agreement under the 293-home framework.

Related lease not yet signed at announcement. Value and rents not disclosed.

MoreLess · SPR Works agreement signed for 39 homes

First Main Works Agreement
· 11:57

Customer
Major energy infrastructure provider; not named in this release.
Scope
39 homes; wider framework 293 homes across six sites.
Payment model
Handover payment followed by monthly rental income under a multi-year lease.
Lease status
Expected shortly; not yet signed at the announcement date.
Economics and timing
Contract value, rents, margin, exact lease term, handover date and group guidance contribution not disclosed.
TRTTransense Technologies

Dowgate reduces holding to 4.54%

Voting interest: 9.37% → 4.54%. 691,365 voting rights.

Threshold crossed 15 September. Reason for the reduction not disclosed.

MoreLess · TRT Dowgate reduces holding to 4.54%

Holding(s) in Company
· 13:25

Shareholder
Dowgate Group Limited; control chain includes Dowgate Wealth.
Previous / new voting interest
9.37% → 4.54%.
Voting rights
691,365; no financial-instrument voting rights.
Threshold / notification
15 / 16 September 2026.
Change
Reduction of 4.83 percentage points.Calculated
Transaction economics
Sale prices, proceeds and reasons not disclosed.
SPRSpringfield Properties

Buyback launched for up to 5% of shares

Up to 5,957,372 shares — approximately 5% of capital.

Held in treasury for employee schemes. No fixed cash budget disclosed.

MoreLess · SPR Buyback launched for up to 5% of shares

Launch of Share Buyback Programme
· 09:59

Start / end
16 September 2026; ends by the 2026 AGM or earlier when the cap is reached.
Maximum shares
5,957,372, approximately 5% of issued capital.
Broker
Cavendish Capital Markets.
Price limits
Minimum 0.125p; maximum 5% above the preceding five-business-day average mid-price.
Treatment
Treasury stock for employee share schemes.
Volume qualification
Purchases may exceed 25% of average daily volume.
Cash budget
No fixed sterling budget disclosed.
TRTTransense Technologies

FY26 results due 22 September

Results and investor presentation: 22 September 2026.

Presentation at 16:00 BST. No trading update.

MoreLess · TRT FY26 results due 22 September

Notice of Results
· 07:00

Reporting period
Year ended 30 June 2026.
Results and presentation
22 September 2026; Investor Meet Company at 16:00 BST.
Presenters
Nigel Rogers, Ryan Maughan and Melvyn Segal.
Shareholder action
Advance questions by 09:00 BST on 21 September, or during the event.
Financial update
Not disclosed.
TRTTransense Technologies

Continental funds six-month development programme

Funded six-month development programme. Production expected Q2 2027, subject to successful development.

Board expects >£0.7m annual deployment revenue. Not a guaranteed order.

MoreLess · TRT Continental funds six-month development programme

Contract Award
· 07:00

Customer
Continental.
Development
Funded six-month programme.
Production timing
Expected Q2 2027, after successful development.
Revenue expectation
Board expects annual deployment revenue exceeding £0.7m.
Commercial terms
Funding amount, contract value, minimum volumes, duration and margin not disclosed.
Guidance treatment
No quantified revision to group earnings guidance.
SPRSpringfield Properties

FY26 results

Year ended 31 May 2026; comparatives FY25.

Group revenue
£243.7mFY25 £280.6m
Adj. PBT
£12.9mFY25 £20.1m
Basic EPS
7.91pFY25 11.86p

Land-sale revenue £14.1m vs £60.5m. Proposed dividend 3p vs 2p.

What changed

Net bank cash £1.2m at 31 May; net debt including leases £3.7m. £20.7m deferred consideration paid after year end.

MoreLess · SPR FY26 results

Final Results and Publication of Annual Report
· 07:00

Period
Year ended 31 May 2026; comparatives FY25.
Revenue
£243.7m / £280.6m; private £165.0m / £155.8m; affordable £54.3m / £49.4m; land £14.1m / £60.5m.
Profit / margin
PBT £11.9m / £19.0m; adjusted £12.9m / £20.1m; gross margin 16.4% / 18.6%.
EPS
Basic 7.91p / 11.86p; adjusted 8.51p / 12.66p.
Operating cash flow
£31.821m / £30.065m, after tax.
Liquidity
Cash £24.154m; bank debt £22.961m; lease liabilities £4.932m.
Post-year-end
£20.7m deferred consideration paid; £12.0m land sale.
Dividend
Proposed 3.0p / 2.0p.
Activity
735 / 799 completions; private reservations steady.
Guidance / order book
No quantified earnings revision or forward order-book value.
IGPIntercede

Chair buys 100,000 shares

Royston Hoggarth bought 100,000 shares at 116.5p. Holding: 1.60%.

Separately, 200,000 EMI options exercised at 38p. Option holder not identified.

MoreLess · IGP Chair buys 100,000 shares

Exercise of Options, PDMR Shareholding & TVR
· 07:00

Person / role
Royston Hoggarth, Chairman; purchase outside a trading venue.
Transaction / shares / price
100,000 shares at 116.5p on 14 September 2026.
Gross purchase value
£116,500.00, before costs.Calculated
Resulting interest
973,206 shares (1.60%); 824,766 direct and 148,440 spouse.
Option exercise
200,000 EMI options at 38p..
Admission
Expected 17 September 2026 at 08:00.
Post-admission capital
61,386,452 issued; 373,906 treasury; 61,012,546 voting rights.
Option exercise proceeds
£76,000.Calculated
SPRSpringfield Properties

Shareholders approve buyback authority

Both resolutions passed with 99.78% support.

Initial programme intended: up to 5,957,372 shares. Launch to be announced separately.

MoreLess · SPR Shareholders approve buyback authority

Result of General Meeting
· 12:36

Meeting
10 September 2026; both resolutions passed with 99.78% support.
Intended programme
Up to 5,957,372 shares.
Maximum authority
11,904,240 shares.
Timing
Formal commencement to be announced separately.
Cash budget
No fixed sterling budget disclosed.
IHCInspiration Healthcare

H1 FY27 trading update

Six months to 31 July 2026; comparative H1 FY26.

Group revenue
£22.0mPrior H1 £24.0m
SLE revenue
£12.7mUnderlying growth +38%
Net debt
£5.2mExcludes leases · 31 Jul 26

Prior half included £6.5m of one-off exports. SLE underlying revenue +38%.

What changed

FY27 expected slightly ahead of market expectations. Micrel agreement ends 31 January 2027.

MoreLess · IHC H1 FY27 trading update

Trading update for six months ended 31 July 2026
· 07:00

Period
Six months to 31 July 2026; comparative H1 FY26.
Group revenue
£22.0m / £24.0m; prior one-off exports £6.5m.
Divisions
SLE £12.7m, underlying +38%; Airon £1.6m / £1.1m; MedTech £7.6m / £7.1m.
Net debt, excluding leases
£5.2m at 31 July; £5.1m at 31 January 2026.
Guidance
Full year expected slightly ahead of market expectations.
Distribution change
Micrel agreement ends 31 January 2027, previously announced.
Other financials
Profit, EPS, margins, operating cash flow and order-book value not quantified.
IGPIntercede

Chair buys 51,352 shares

Royston Hoggarth bought 51,352 shares at 111p. Holding: 1.44%.

Separately, 150,000 EMI options exercised at 38p. Option holder not identified.

MoreLess · IGP Chair buys 51,352 shares

Exercise of Options, PDMR Shareholding & TVR
· 07:00

Person / role
Royston Hoggarth, Chairman; purchase outside a trading venue.
Transaction / shares / price
51,352 shares at 111p on 7 September 2026.
Gross purchase value
£57,000.72, before costs.Calculated
Resulting interest
873,206 shares (1.44%); 724,766 direct and 148,440 spouse.
Option exercise
150,000 EMI options at 38p..
Admission
Expected 11 September 2026 at 08:00.
Post-admission capital
61,186,452 issued; 373,906 treasury; 60,812,546 voting rights.
Option exercise proceeds
£57,000.Calculated
ENSIEnSilica

Milan engineering centre planned

RNS Reach · non-regulatory

Space and communications centre planned. Initial hiring: 20 engineers over six months.

Costs and incremental revenue not disclosed.

MoreLess · ENSI Milan engineering centre planned

EU Space & Comms Centre of Excellence
· 07:00

Location and scope
Milan, Italy; Space & Comms Centre of Excellence.
Hiring plan
Initial 20 engineers over six months.
European presence
Adds to Budapest design and Munich sales locations.
Costs and returns
Capital expenditure, operating costs, new committed orders and incremental revenue not disclosed.
Guidance treatment
Not disclosed.
SPRSpringfield Properties

Voting rights

92,457 employee-option shares issued.

119,514,287 voting rights. No treasury shares.

MoreLess · SPR Voting rights

Total Voting Rights
· 12:26

New shares
92,457 ordinary shares; nominal value 0.125p.
Capital / voting rights
119,514,287 issued shares and voting rights; no treasury shares.
Admission
Covered by existing block listing.
Exercise economics
Exercise price and proceeds not specified.
TRTTransense Technologies

Unison collaboration on torque sensing

RNS Reach · non-regulatory

SAWsense torque sensing used in a hybrid-electric flight demonstrator.

Contract value, revenue commitments and production timetable not disclosed.

MoreLess · TRT Unison collaboration on torque sensing

Transense and Unison Collaboration
· 07:00

Counterparty
Unison, a GE Aerospace company.
Scope
Torque sensing; Unison leads engineering, qualification and integration.
Demonstration
Hybrid-electric flight above 30,000 feet and a transatlantic crossing.
Economics and timing
Contract value, revenue commitments, duration and production timetable not disclosed.
SPRSpringfield Properties

FY26 results due 15 September

Results: 15 September. Investor webinar: 16 September, 09:00 BST.

MoreLess · SPR FY26 results due 15 September

Notice of Results
· 07:00

Reporting period
Year ended 31 May 2026.
Results release
15 September 2026.
Analyst presentation
9.00am BST on 15 September 2026.
Investor webinar
9.00am BST on 16 September 2026.
Shareholder action
Webinar registration is available through Equity Development.
Financial or trading update
No trading figures or guidance change were disclosed.
SPRSpringfield Properties

Buyback proposed, subject to shareholder approval

Initial cap: 5,957,372 shares. Maximum authority: 11,904,240.

Independent shareholder approval required on 10 September. Shares to be held in treasury.

MoreLess · SPR Buyback proposed, subject to shareholder approval

Share Buyback, Rule 9 Waiver and Notice of GM
· 07:00

Event
Proposed on-market share buyback programme and Rule 9 waivers.
Initial programme
Up to 5,957,372 Ordinary Shares.
Maximum authority
Up to 11,904,240 Ordinary Shares.
Shareholder approval
Independent Shareholder vote at 12.00 noon on 10 September 2026.
Purchase price limits
At least 0.125p and no more than 5% above the preceding five-business-day average middle-market price.
Treatment of shares
Repurchased shares will be held in treasury for future employee or other share schemes.
Concert Party position
41.49% currently; up to 46.08% after the maximum buyback, or 46.76% including full exercise of the CEO options.
Conditionality
The Panel waiver is conditional on approval of the Rule 9 Waiver Resolutions.
Financial or trading update
No pro-forma cash impact, programme cost or trading update was disclosed.
SPRSpringfield Properties

170 plots sold for £12m cash

170 plots sold for £12m cash. £6.5m used for the final Mactaggart & Mickel payment.

Remaining deferred consideration satisfied. Post-transaction net cash not disclosed.

MoreLess · SPR 170 plots sold for £12m cash

Land Sale and Final Deferred Consideration Payment
· 07:00

Asset sold
Land equating to 170 plots at a Central Scotland site.
Cash proceeds
£12.0m received in full on completion.
Land-sale profitability
The company described the sale as profitable, but the profit was not quantified.
Use of proceeds
£6.5m used for the final Mactaggart & Mickel consideration payment.
Original deferred consideration
£30.8m, payable proportionally as homes were sold over five years.
Outstanding at 31 May 2026
£20.7m.
Current status
The remaining deferred consideration has been satisfied.
Guidance treatment
No trading guidance change was disclosed.
Pro-forma liquidity
Cash or net cash after the sale and final payment was not disclosed.
HERCHerculesFormer holding

Academy receives approximately £310k in funded awards

Approximately £310k of funded training awards. Prison delivery expanded from three to seven sites.

Commercial pilots underway. Values, margins and conversion dates not disclosed.

MoreLess · HERC Academy receives approximately £310k in funded awards

Hercules Academy Growth Update
· 07:00

Event
Academy growth update covering funded awards, delivery footprint and commercial pilots.
Funded awards
Approximately £310,000 through Warwickshire County Council.
Provider status
Appointed to the West Midlands Combined Authority Preferred Provider List.
Prison delivery
Seven establishments, up from three in 2025, with engagement at a further seven sites.
Commercial pilots
Programmes underway with major infrastructure clients; further opportunities are being evaluated.
Training volume
More than 2,500 individuals trained since establishment.
Commercial terms
Pilot values, margins and conversion timing were not disclosed.
Guidance treatment
No formal group guidance change was disclosed.
HERCHerculesFormer holding

Pay & bill system introduced

New platform implemented. Wider ERP programme continues.

Financial benefits not quantified.

MoreLess · HERC Pay & bill system introduced

Successful Implementation of Pay & Bill Platform
· 07:00

Announcement
New pay-and-bill platform implemented; wider ERP programme remains in progress.
Financial benefits
Not quantified.
IHCInspiration Healthcare

2.76m nil-cost options awarded

2,759,141 nil-cost options. 1,822,268 to the CEO and CFO.

FY29 EBITDA and cash-conversion conditions. Actual hurdles not disclosed.

MoreLess · IHC 2.76m nil-cost options awarded

Grant of awards under Long-Term Incentive Plan
· 07:00

Figure
2.76m total options
Figure
1.82m to CEO/CFO
Figure
FY29 performance period
SPRSpringfield Properties

Share scheme return

Share scheme return for 2 February–1 August 2026.

MoreLess · SPR Share scheme return

Block Listing Six Monthly Return
· 17:08

SAYE issued
373 shares
Performance plan issued
274,011 shares
Performance plan block increase
725,435 shares
Unallotted balances
SAYE 100,791; CSOP 591,291; employee plan 1,801,647; performance plan 485,473
Shares in issue
119,421,830
IGPIntercede

Approximately $2.6m of orders and renewals

Approximately $2.6m of new orders and renewals.

A further $1.65m of potential renewals through February 2030 — not committed orders.

MoreLess · IGP Approximately $2.6m of orders and renewals

Contract Wins
· 07:00

Figure
c.$2.6m orders/renewals
Figure
c.$1.65m potential future renewals
HERCHerculesFormer holding

Power & Energy division

Advantage NRG activity reorganised into a separately reported division.

£20.8m of FY26 secured work recorded.

MoreLess · HERC Power & Energy division

Launch of Power & Energy Services Division
· 07:00

Figure
£20.8m FY26 secured work
ENSIEnSilica

€1.7m satellite ASIC contract

€1.7m second-phase contract. Delivery over approximately 10 months.

MoreLess · ENSI €1.7m satellite ASIC contract

Second Phase Contract Win & New Project Update
· 07:00

Figure
€1.7m contract
Figure
c.10-month delivery
ENSIEnSilica

Voting rights

Post-fundraise voting rights confirmed at 134,235,414.

MoreLess · ENSI Voting rights

Total Voting Rights
· 17:00

Issued shares
134,235,414
Voting rights
134,235,414
Treasury shares
Nil
HERCHerculesFormer holding

Brusk Korkmaz buys 113,000 shares

Brusk Korkmaz bought 113,000 shares at 43.18p average (£48,793.40).

MoreLess · HERC Brusk Korkmaz buys 113,000 shares

Director Dealing
· 10:40

Person
Brusk Korkmaz
Role
Chief Executive Officer
Transaction
Purchase of 113,000 shares
Price
43.18p average
Gross value
£48,793.40Calculated
Resulting holding
18,383,846 shares / 22.82%
Transaction date
31 July 2026
ENSIEnSilica

Holding notification

Post-fundraise major-holder positions disclosed; Esterhuyzen became the largest holder at 16.39%.

MoreLess · ENSI Holding notification

Holding(s) in Company
· 15:00

Esterhuyzen Ltd
22,000,000 shares / 16.39%; 6,000,000 acquired in fundraise
Ian Lankshear
16,040,358 / 11.95%
Richard Ashley Hamer
5,857,490 / 4.36%
Marc Castells
5,746,554 / 4.28%
Richard Neil Marley
4,671,554 / 3.48%
HERCHerculesFormer holding

Brusk Korkmaz buys 87,500 shares

Brusk Korkmaz bought 87,500 shares at 41.0p (£35,875).

MoreLess · HERC Brusk Korkmaz buys 87,500 shares

Director Dealing
· 12:15

Person
Brusk Korkmaz
Role
Chief Executive Officer
Transaction
Purchase of 87,500 shares
Price
41.0p
Gross value
£35,875Calculated
Resulting holding
18,358,346 shares / 22.79%
Transaction date
28 July 2026
ENSIEnSilica

General meeting result and voting rights

Fundraising resolutions passed; post-admission share count set at 134,235,414.

MoreLess · ENSI General meeting result and voting rights

Result of General Meeting and Total Voting Rights
· 11:00

General Meeting
All resolutions passed
Admission
29 July 2026
Post-admission shares/votes
134,235,414
Purpose
Complete second fundraising tranche and retail offer
HERCHerculesFormer holding

Brusk Korkmaz buys 100,000 shares

Brusk Korkmaz bought 100,000 shares at 39.75p average (£39,750).

MoreLess · HERC Brusk Korkmaz buys 100,000 shares

Director Dealing
· 11:44

Person
Brusk Korkmaz
Role
Chief Executive Officer
Transaction
Purchase of 100,000 shares
Price
39.75p average
Gross value
£39,750Calculated
Resulting holding
18,270,846 shares / 23.68%
Transaction date
24 July 2026
HERCHerculesFormer holding

Cooper Parry appointed auditor

Cooper Parry appointed auditor, replacing S&W Partners Audit.

MoreLess · HERC Cooper Parry appointed auditor

Change of Auditor
· 07:00

New auditor
Cooper Parry Group Ltd
Outgoing auditor
S&W Partners Audit Limited
Process
Formal tender
Resignation statement
No matters reported for shareholder or creditor attention
IHCInspiration Healthcare

AGM result

All AGM resolutions passed.

MoreLess · IHC AGM result

Result of AGM
· 14:01

Meeting
Annual General Meeting held 23 July 2026
Outcome
All proposed resolutions passed
HERCHerculesFormer holding

Martin Tedham buys 285,160 shares

Martin Tedham bought 285,160 shares at 34.75p (£99,093.10).

MoreLess · HERC Martin Tedham buys 285,160 shares

Director Dealing
· 11:45

Person
Martin Tedham
Role
Non-Executive Director
Transaction
Purchase of 285,160 shares
Price
34.75p
Gross value
£99,093.10Calculated
Resulting holding
10,934,648 shares / 13.57%
Transaction date
22 July 2026
IHCInspiration Healthcare

Trading in line

Management reports trading in line. No new quantified guidance.

MoreLess · IHC Trading in line

AGM Statement
· 07:00

Announcement
Current trading described as in line; no new quantified guidance.
HERCHerculesFormer holding

Martin Tedham via Wasdell Packaging Group buys 50,000 shares

Martin Tedham via Wasdell Packaging Group bought 50,000 shares at 32.0p (£16,000).

MoreLess · HERC Martin Tedham via Wasdell Packaging Group buys 50,000 shares

Director Dealing
· 10:26

Person
Martin Tedham via Wasdell Packaging Group
Role
Non-Executive Director / connected vehicle
Transaction
Purchase of 50,000 shares
Price
32.0p
Gross value
£16,000Calculated
Resulting holding
10,520,047 shares / 13.06%
Transaction date
22 July 2026
TRTTransense Technologies

Translogik appoints more distributors

Additional distributors appointed.

Financial commitments and order volumes not disclosed.

MoreLess · TRT Translogik appoints more distributors

Transense appoints distributors for Translogik
· 07:00

Announcement
Additional Translogik distributors appointed across new territories.
Financial commitments / orders
Not disclosed.
ENSIEnSilica

€1.1m satellite follow-on order

€1.1m: €0.35m of samples and €0.75m of product enhancements.

Material supply revenue expected from 2029.

MoreLess · ENSI €1.1m satellite follow-on order

Follow on Satellite Orders
· 07:00

Figure
€1.1m order
Figure
€0.35m samples
Figure
€0.75m enhancements
Figure
Supply growth expected from 2029
HERCHerculesFormer holding

Martin Tedham buys 110,000 shares

Martin Tedham bought 110,000 shares at 31.0p (£34,100).

MoreLess · HERC Martin Tedham buys 110,000 shares

Director Dealing
· 12:17

Person
Martin Tedham
Role
Non-Executive Director
Transaction
Purchase of 110,000 shares
Price
31.0p
Gross value
£34,100Calculated
Resulting holding
10,470,047 shares / 13.14%
Transaction date
17 July 2026
IHCInspiration Healthcare

Two AGM resolutions withdrawn

Resolutions 10 and 11 withdrawn. Other resolutions unaffected.

MoreLess · IHC Two AGM resolutions withdrawn

Withdrawal of AGM Resolutions 10 and 11
· 07:00

Announcement
Two AGM authorities withdrawn before the meeting.
IGPIntercede

CFO exercises 500,000 options

Nitil Patel exercised 500,000 EMI options at 38p.

Holding after exercise: 560,097 shares / 0.92%.

MoreLess · IGP CFO exercises 500,000 options

Exercise of Options, PDMR Shareholding & TVR
· 07:00

PDMR
Nitil Patel, CFO
Options exercised
500,000
Exercise price
38.0p
Exercise cost
£190,000Calculated
Resulting holding
560,097 shares / 0.92%
Issued shares after admission
61,036,452
Treasury shares
373,906
Voting rights
60,662,546
ENSIEnSilica

Director option awards

2,166,000 options at 0.1p. FY29/FY30 EBITDA and TSR conditions.

Total outstanding options: 10,188,526.

MoreLess · ENSI Director option awards

Grant of Options
· 07:00

Director options
2,166,000
Mark Hodgkins
393,000
Ian Lankshear
1,212,000
Kristoff Rademan
561,000
Exercise price
0.1p
Performance conditions
FY29/FY30 EBITDA and TSR
Total outstanding options
10,188,526
HERCHerculesFormer holding

Advantage NRG secures £3.4m of work

£3.4m National Grid work lifts FY26 Advantage NRG secured work to £20.8m.

MoreLess · HERC Advantage NRG secures £3.4m of work

Advantage NRG secures £3.4m of contracted works
· 07:00

Figure
£3.4m new work
Figure
£20.8m FY26 secured work
HERCHerculesFormer holding

£6.1m of new water-sector work

£6.1m of new water-sector work; FY26 Civil Projects awards reached £15.7m.

MoreLess · HERC £6.1m of new water-sector work

Civil Projects Division Secures £6.1m of Contracts
· 07:00

Figure
£6.1m new contracts
Figure
£15.7m FY26 awards
Figure
FY25 division revenue £13.5m
HERCHerculesFormer holding

Martin Tedham via Wasdell Packaging Group buys 305,000 shares

Martin Tedham via Wasdell Packaging Group bought 305,000 shares at 25.35p average (£77,317.50).

MoreLess · HERC Martin Tedham via Wasdell Packaging Group buys 305,000 shares

Director Dealing
· 11:18

Person
Martin Tedham via Wasdell Packaging Group
Role
Non-Executive Director / connected vehicle
Transaction
Purchase of 305,000 shares
Price
25.35p average
Gross value
£77,317.50Calculated
Resulting holding
10,470,047 shares / 13.00%
Transaction date
9 July 2026
ENSIEnSilica

Retail offer result & GM notice

Retail offer result published. General meeting announced.

MoreLess · ENSI Retail offer result & GM notice

Result of Retail Offer and Notice of GM
· 14:05

Announcement
Retail offer result published. General meeting announced.
HERCHerculesFormer holding

Brusk Korkmaz buys 100,000 shares

Brusk Korkmaz bought 100,000 shares at 29.25p (£29,250).

MoreLess · HERC Brusk Korkmaz buys 100,000 shares

Director Dealing
· 09:23

Person
Brusk Korkmaz
Role
Chief Executive Officer
Transaction
Purchase of 100,000 shares
Price
29.25p
Gross value
£29,250Calculated
Resulting holding
18,170,846 shares / 22.56%
Transaction date
8 July 2026
ENSIEnSilica

Retail offer launched for up to £1m

Retail offer launched for up to £1m on the placing terms.

MoreLess · ENSI Retail offer launched for up to £1m

Retail Offer to raise up to £1 million
· 07:01

Figure
Up to £1m
Figure
91p issue price
TRTTransense Technologies

Richard Pearce to join as Finance Director

Melvyn Segal to retire as CFO at the November AGM; then one year as a non-executive director.

Richard Pearce joins as Finance Director on 1 September.

MoreLess · TRT Richard Pearce to join as Finance Director

Board Changes
· 07:00

Outgoing CFO
Melvyn Segal
Retirement
November 2026 AGM
Transition
One further year as non-executive director
Successor
Richard Michael Pearce ACA
Start date
1 September 2026
ENSIEnSilica

£14m raised at 91p

£14m gross at 91p per share, before the retail offer.

New shares approximately 11.5% of the pre-raise share count.

MoreLess · ENSI £14m raised at 91p

Result of oversubscribed Placing and Subscription
· 07:00

Figure
£14m gross
Figure
91p issue price
New shares / existing shares
c.11.5% of the pre-raise share count, before the retail offer.Calculated
ENSIEnSilica

Equity raise of up to £15m proposed at 91p

A second 2026 equity raise proposed: up to £15m at 91p.

MoreLess · ENSI Equity raise of up to £15m proposed at 91p

Proposed equity fundraising via ABB
· 17:01

Figure
Up to £15m gross
Figure
91p issue price
HERCHerculesFormer holding

CEO purchase

Brusk Korkmaz bought at an average 28.14p.

MoreLess · HERC CEO purchase

Director Dealing
· 11:13

Person
Brusk Korkmaz
Role
Chief Executive Officer
Average price
28.14p
Resulting holding
18,070,846 shares / 22.44%
SPRSpringfield Properties

Holding notification

Downing-managed funds increased from 3.02% to 4.00%.

MoreLess · SPR Holding notification

Holding(s) in Company
· 11:47

Shareholder
Client funds managed by Downing LLP
Previous position
3.02%
New position
4.00% / 4,780,139 shares
Threshold crossed
30 June 2026
HERCHerculesFormer holding

Paula Wheatcroft buys 37,000 shares

Paula Wheatcroft bought 37,000 shares at 27.0p (£9,990).

MoreLess · HERC Paula Wheatcroft buys 37,000 shares

PCA Dealing
· 13:51

Person
Paula Wheatcroft
Role
Person closely associated with CFO Paul Wheatcroft
Transaction
Purchase of 37,000 shares
Price
27.0p
Gross value
£9,990Calculated
Resulting holding
80,200 shares / 0.10% combined
Transaction date
1 July 2026
TRTTransense Technologies

Translogik appoints North American distributor

North American distributor appointed.

No minimum order or revenue commitment disclosed.

MoreLess · TRT Translogik appoints North American distributor

North American Distribution Partner for Translogik
· 07:00

Announcement
New North American distributor appointed for Translogik.
IHCInspiration Healthcare

Annual report published; AGM on 23 July

FY26 annual report published. AGM: 23 July 2026, 12:00 BST.

MoreLess · IHC Annual report published; AGM on 23 July

Annual Report and Notice of AGM
· 11:00

Reporting period
Year ended 31 January 2026
AGM
23 July 2026 at 12:00 BST
HERCHerculesFormer holding

Invoice facility increased to £20m

Invoice-discount facility £16m → £20m. £5m of term loans arranged.

Approximately £4m linked to the Advantage NRG earn-out.

MoreLess · HERC Invoice facility increased to £20m

Increase in Working Capital Facility & Term Loans
· 07:00

Figure
Invoice facility £16m → £20m
Figure
£5m term loans
Figure
c.£4m earn-out funding
HERCHerculesFormer holding

AGM result

All 12 AGM resolutions passed; lowest support was 99.80%.

MoreLess · HERC AGM result

Result of AGM
· 15:30

Resolutions
12 passed
Lowest support
Resolution 12: 99.80% for
Votes against resolution 12
107,974 / 0.20%
IGPIntercede

FY26 results

Revenue
£17.2mFY25 £17.7m
Adj. EBITDA
£4.0mFY25 £4.5m
Cash
£20.0mDebt-free · 31 Mar 26

Recurring revenue £11.4m / 66% of total. Operating cash flow £3.1m.

MoreLess · IGP FY26 results

Final Results
· 07:00

Figure
Revenue £17.2m (-2.8%)
Figure
Adj EBITDA £4.0m
Figure
Recurring revenue 66%
Figure
Cash £20.0m
HERCHerculesFormer holding

AGM statement

Some project starts delayed. IT, systems and controls investment continues.

No quantified guidance change.

MoreLess · HERC AGM statement

AGM Statement
· 07:00

Growth drivers
Organic growth and targeted M&A
Investment
IT infrastructure, systems and controls
Operational issue
Some project commencement delays
Guidance
No quantified change disclosed
ENSIEnSilica

FY26 trading statement

Revenue
£27.5m+51% · unaudited
EBITDA
£4.7mPrevious guidance £3.5m–£4.5m
Cash
£7.5mAfter March fundraising

What changed

FY27 revenue guidance: £32m–£34m, approximately 80% covered.

Monthly operating cash generation targeted to turn positive by end-FY27.

MoreLess · ENSI FY26 trading statement

Trading Statement
· 07:00

Figure
Revenue £27.5m (+51%)
Figure
EBITDA £4.7m
Figure
Cash £7.5m
Figure
FY27 revenue £32-34m
TRTTransense Technologies

Ryan Maughan buys 16,654 shares

Ryan Maughan bought 16,654 shares at 47.99p (£7,992.25).

MoreLess · TRT Ryan Maughan buys 16,654 shares

Director/PDMR Shareholding - acquisition of shares
· 16:11

Person
Ryan Maughan
Role
Managing Director
Transaction
Purchase of 16,654 shares
Price
47.99p
Gross value
£7,992.25Calculated
Resulting holding
126,217 shares / 0.83%
TRTTransense Technologies

FY26 revenue expected at least £4.6m

FY26 revenue now at least £4.6m. Adjusted EBITDA at least £0.5m.

Adjusted PBT around break-even. Cash £1.12m at 31 May.

MoreLess · TRT FY26 revenue expected at least £4.6m

Trading update and Investor Meet Company seminar
· 07:00

Figure
Revenue at least £4.6m
Figure
Adj EBITDA at least £0.5m
Figure
Adj PBT around break-even
Figure
Cash £1.12m
HERCHerculesFormer holding

Skills whitepaper

Skills whitepaper published.

MoreLess · HERC Skills whitepaper

Hercules Launches Landmark Skills Whitepaper
· 07:00

Announcement
Skills whitepaper published.
IHCInspiration Healthcare

FY26 results

Revenue
£47.5m+24%
Adj. EBITDA
£2.8mFY25 £0.2m
Gross margin
43.7%FY25 42.8%

Operating cash inflow £7.5m vs £1.5m outflow.

What changed

Net debt £5.1m at year end; £5.6m at 31 May. FY27 trading in line.

MoreLess · IHC FY26 results

Final Results
· 07:00

Figure
Revenue £47.5m (+24%)
Figure
Adj EBITDA £2.8m
Figure
Operating cash inflow £7.5m
Figure
Net debt £5.6m at 31 May
IGPIntercede

Swissbit partnership

Partnership extended.

Commercial terms and committed revenue not disclosed.

MoreLess · IGP Swissbit partnership

Extension of Partnership with Swissbit
· 07:00

Announcement
Swissbit partnership extended, supporting hardware-backed identity distribution.
Commercial terms / committed revenue
Not disclosed.
ENSIEnSilica

Edge AI ASIC completes tape-out

ASIC programme completed tape-out.

No new supply-volume or revenue-timing figures.

MoreLess · ENSI Edge AI ASIC completes tape-out

Edge AI ASIC Supply Contract Completes Tape-Out
· 07:57

Announcement
Edge-AI ASIC completed tape-out, moving the programme toward production supply.
ENSIEnSilica

25th anniversary

Company marks its 25th anniversary.

MoreLess · ENSI 25th anniversary

25th Company Anniversary
· 07:00

Announcement
Company marks its 25th anniversary.
HERCHerculesFormer holding

H1 results

Revenue £59.2m, +8%. Underlying EBITDA £1.7m vs £2.6m.

Cash £2.7m vs £9.8m. No interim dividend.

MoreLess · HERC H1 results

Interim Results
· 10:01

Figure
Revenue £59.2m (+8%)
Figure
Underlying EBITDA £1.7m (-35%)
Figure
Cash £2.7m
SPRSpringfield Properties

FY26 trading update

Revenue approximately £245m. Adjusted PBT in line.

Year-end net bank cash approximately £1m vs expected net debt of approximately £10m.

MoreLess · SPR FY26 trading update

Trading Update
· 07:00

Figure
Revenue c.£245m
Figure
Expected net debt c.£10m
Figure
Actual net cash c.£1m
Figure
c.£11m positive variance
HERCHerculesFormer holding

AGM notice

AGM scheduled for 23 June 2026 at 11:30.

MoreLess · HERC AGM notice

Notice of Annual General Meeting
· 16:40

AGM date
23 June 2026
Time
11:30
Venue
Hercules Court, Lakeside Business Park, South Cerney
IHCInspiration Healthcare

FY26 results due 16 June

FY26 results scheduled for 16 June 2026.

MoreLess · IHC FY26 results due 16 June

Notice of Results
· 07:01

Reporting period
Year ended 31 January 2026
Results date
16 June 2026
Analyst briefing
11:00 BST
Investor presentation
12:30 BST
IHCInspiration Healthcare

Non-core infusion products transferred out

Non-core infusion products transferred out; FY27 net debt expected to fall by about 20%.

MoreLess · IHC Non-core infusion products transferred out

Transfer of Non-Core Products to Focus on Neonatal
· 07:00

Figure
FY26 infusion revenue £9.7m
Figure
c.25% contribution margin
Figure
c.20% FY27 net-debt reduction expected
SPRSpringfield Properties

Voting rights

266,316 option-exercise shares issued; voting rights increased to 119,421,830.

MoreLess · SPR Voting rights

Total Voting Rights
· 15:57

New shares issued
266,316
Reason
Employee option exercises
Issued shares / voting rights
119,421,830
Treasury shares
Nil
ENSIEnSilica

$75m seven-year automotive supply contract

$75m seven-year automotive supply contract; c.$4m FY27 revenue expected.

MoreLess · ENSI $75m seven-year automotive supply contract

$75m Contract Win
· 07:00

Figure
c.$75m over 7 years
Figure
c.$4m FY27 revenue
Figure
No further design/tape-out
HERCHerculesFormer holding

Share trading restored

Share trading restored after publication of FY25 accounts.

MoreLess · HERC Share trading restored

Restoration - Hercules plc
· 07:30

Announcement
Share trading restored after publication of FY25 accounts.
HERCHerculesFormer holding

FY25 results and H1 trading update

FY25 revenue grew. Accounts received a qualified audit opinion. H1 profitability was lower.

MoreLess · HERC FY25 results and H1 trading update

Final Results and H1 Trading Update
· 07:00

Figure
Revenue £121.2m (+19%)
Figure
Underlying EBITDA £6.4m
Figure
Statutory PBT £0.9m
Figure
Cash generated £7.6m
IGPIntercede

OneSpan partnership announced

Partnership with OneSpan covering distribution and product integration.

MoreLess · IGP OneSpan partnership announced

Partnership with OneSpan
· 07:00

Announcement
Partnership with OneSpan covering distribution and product integration.
IGPIntercede

FY26 results due 23 June

FY26 results scheduled for 23 June; investor presentation on 25 June.

MoreLess · IGP FY26 results due 23 June

Notice of Results and Investor Presentation
· 07:00

Reporting period
Year ended 31 March 2026
Results date
23 June 2026
Investor presentation
25 June 2026 at 15:00 BST
Presenters
CEO Klaas van der Leest, CPO Allen Storey and CFO Nitil Patel
TRTTransense Technologies

Option awards

305,000 options granted. Total outstanding: 1,895,000.

Ryan Maughan: 100,000 at 10p, with 150p and 200p share-price vesting hurdles.

MoreLess · TRT Option awards

Grant of Options
· 07:00

Ryan Maughan award
100,000 options
Employee awards
205,000 options
Exercise price
10p
Vesting hurdles
Two-thirds at 150p; one-third at 200p; each for 10 consecutive trading days
Total outstanding options
1,895,000 / 11.53% of issued capital
IGPIntercede

CEO and CFO join share incentive scheme

CEO and CFO each committed £1,800 to partnership shares with one-for-one matching shares.

MoreLess · IGP CEO and CFO join share incentive scheme

Share Incentive Scheme
· 14:50

CEO commitment
£1,800
CFO commitment
£1,800
Matching ratio
One matching share per partnership share
Shares credited
2,956 each, including matching shares
Reference price
121.75p
CEO resulting holding
2,322,683 / 3.9%
CFO resulting holding
60,097 / 0.1%
ENSIEnSilica

Holding notification

Maven Capital Partners: 3.768752% / 4,442,500 → 2.793160% / 3,292,500.

MoreLess · ENSI Holding notification

Holding(s) in Company
· 14:50

Shareholder
Maven Capital Partners
Previous position
3.768752% / 4,442,500
New position
2.793160% / 3,292,500
Context
Position reduced by 1,150,000 shares.
ENSIEnSilica

Holding notification

Richard Neil Marley: 4.05% → 3.96% / 4,671,554.

MoreLess · ENSI Holding notification

Holding(s) in Company
· 07:00

Shareholder
Richard Neil Marley
Previous position
4.05%
New position
3.96% / 4,671,554
Context
Holding moved below 4%.
SPRSpringfield Properties

Block admission sought for 725,435 scheme shares

Block admission sought for 725,435 Performance Share Plan shares.

MoreLess · SPR Block admission sought for 725,435 scheme shares

Block Listing Application
· 13:00

Block admission
725,435 shares
Scheme
Performance Share Plan
Expected admission
11 May 2026
Issued share capital at announcement
119,155,514; unchanged
TRTTransense Technologies

Translogik launches high-pressure tyre tool

High-pressure tyre inspection tool launched.

Revenue contribution and customer commitments not disclosed.

MoreLess · TRT Translogik launches high-pressure tyre tool

Launch of high-pressure tyre inspection tool
· 07:00

Announcement
New Translogik product broadens the inspection offering.
Revenue / customer commitments
Not disclosed.
ENSIEnSilica

Holding notification

Maven Capital Partners: 4.6113% → 3.768752% / 4,442,500.

MoreLess · ENSI Holding notification

Holding(s) in Company
· 17:35

Shareholder
Maven Capital Partners
Previous position
4.6113%
New position
3.768752% / 4,442,500
Context
Position reduced by 457,500 shares.
ENSIEnSilica

Voting rights

Issued shares and voting rights updated to 117,877,230.

MoreLess · ENSI Voting rights

Total Voting Rights
· 17:30

Issued shares
117,877,230
Voting rights
117,877,230
Treasury shares
Nil
TRTTransense Technologies

Nigel Rogers buys 12,500 shares

Nigel Rogers bought 12,500 shares at 57.98p (£7,247.50).

MoreLess · TRT Nigel Rogers buys 12,500 shares

Director/PDMR Shareholding - acquisition of shares
· 15:00

Person
Nigel Rogers
Role
Executive Chairman
Transaction
Purchase of 12,500 shares
Price
57.98p
Gross value
£7,247.50Calculated
Resulting holding
300,000 shares / 1.97%
TRTTransense Technologies

Ryan Maughan buys 3,409 shares

Ryan Maughan bought 3,409 shares at 58.44p (£1,992.22).

MoreLess · TRT Ryan Maughan buys 3,409 shares

Director/PDMR Shareholding - acquisition of shares
· 13:25

Person
Ryan Maughan
Role
Managing Director
Transaction
Purchase of 3,409 shares
Price
58.44p
Gross value
£1,992.22Calculated
Resulting holding
109,563 shares / 0.72%
ENSIEnSilica

SpaceTech contracts

Space-sector contracts announced.

MoreLess · ENSI SpaceTech contracts

Major SpaceTech Contracts
· 07:00

Announcement
Space-sector contracts for funded development and potential future supply.
TRTTransense Technologies

Further SAWsense investment announced

Additional investment announced to expand SAWsense.

MoreLess · TRT Further SAWsense investment announced

SAWsense investment to accelerate scale-up
· 07:00

Announcement
Additional investment committed to accelerate SAWsense commercialisation.
IGPIntercede

Orders & renewals

New contracts, upsells and renewals announced after the 9 April update.

MoreLess · IGP Orders & renewals

New Contract Upsell Orders and Renewal
· 07:00

Announcement
Post-year-end contracts and renewals for FY27.
ENSIEnSilica

US OTCQX cross-trading

US OTCQX cross-trading announced.

MoreLess · ENSI US OTCQX cross-trading

Cross-Trading on the U.S. OTCQX Market
· 07:00

Announcement
US OTCQX cross-trading announced.
IHCInspiration Healthcare

Singer appointed nominated adviser and joint broker

Singer Capital Markets appointed nominated adviser and joint broker.

MoreLess · IHC Singer appointed nominated adviser and joint broker

Change of Adviser
· 07:00

New adviser
Singer Capital Markets
Role
Nominated adviser and joint broker
Effective
14 April 2026
Existing joint broker
Cavendish Capital Markets
IGPIntercede

FY26 trading update

Revenue approximately £17.2m, −2.8%. Recurring revenue £11.4m / 66%.

Cash £20m, debt-free. New orders and renewals approximately $5.22m.

MoreLess · IGP FY26 trading update

Trading Update, Renewals and New Contract Orders
· 07:00

Figure
Revenue £17.2m (-2.8%)
Figure
Recurring revenue £11.4m (66%)
Figure
Cash £20.0m
Figure
Orders/renewals c.$5.22m
TRTTransense Technologies

Holding notification

Dowgate Group: 10.872967% → 9.37% / 1,426,365 shares.

MoreLess · TRT Holding notification

Holding(s) in Company
· 12:06

Shareholder
Dowgate Group
Previous position
10.872967%
New position
9.37% / 1,426,365 shares
ENSIEnSilica

GM result & share capital

General meeting result, major shareholder and voting rights announced.

MoreLess · ENSI GM result & share capital

Result of GM, Major New Shareholder and TVR
· 11:26

Announcement
General meeting result, major shareholder and voting rights announced.
SPRSpringfield Properties

Voting rights

7,695 option-exercise shares issued; voting rights increased to 119,155,514.

MoreLess · SPR Voting rights

Total Voting Rights
· 14:43

New shares issued
7,695
Reason
Employee option exercises
Issued shares / voting rights
119,155,514
Treasury shares
Nil
HERCHerculesFormer holding

Shares suspended pending FY25 accounts

Shares suspended pending publication of FY25 accounts.

MoreLess · HERC Shares suspended pending FY25 accounts

Suspension - Hercules plc
· 07:30

Announcement
Shares suspended pending publication of FY25 accounts.
ENSIEnSilica

Voting rights

Issued shares and voting rights updated to 106,260,699.

MoreLess · ENSI Voting rights

Total Voting Rights
· 17:00

Issued shares
106,260,699
Voting rights
106,260,699
Treasury shares
Nil
ENSIEnSilica

Selected for UK CHERI programme

Selected for the UK CHERI Adoption Collective.

MoreLess · ENSI Selected for UK CHERI programme

EnSilica selected for UK CHERI Adoption Collective
· 07:00

Announcement
Selected for a UK advanced-computing adoption programme.
Commercial terms
Not disclosed.
ENSIEnSilica

Proposed US OTCQB trading

Plans announced for shares to trade on the US OTCQB market.

MoreLess · ENSI Proposed US OTCQB trading

Intention for shares to trade on OTCQB Market
· 13:20

Announcement
Plans announced for shares to trade on the US OTCQB market.
ENSIEnSilica

Holding notification

Maven Capital Partners: 5.07243% → 4.6113% / 4,900,000.

MoreLess · ENSI Holding notification

Holding(s) in Company
· 11:17

Shareholder
Maven Capital Partners
Previous position
5.07243%
New position
4.6113% / 4,900,000
Context
Share count unchanged; percentage fell after new equity.
HERCHerculesFormer holding

Accounts delayed; suspension scheduled for 1 April

FY25 accounts delayed beyond the AIM deadline.

Shares scheduled for suspension from 1 April 2026.

MoreLess · HERC Accounts delayed; suspension scheduled for 1 April

Delay in Final Results and Temporary Suspension
· 12:00

Announcement
FY25 accounts missed the AIM deadline; shares set for suspension from 1 April.
SPRSpringfield Properties

Director dealing

Sandy and Anne Adam transferred 15.0m shares at nil cost to a family trust; combined interest remained 21.0%.

MoreLess · SPR Director dealing

Director/PDMR Shareholding
· 07:00

Transferors
Sandy Adam, Chairman; Anne Adam, PCA
Shares transferred
15,000,000 total
Breakdown
Sandy 10,000,000; Anne 5,000,000
Consideration
Nil
Resulting combined interest
25,040,120 shares / 21.0%
ENSIEnSilica

Holding notification

Esterhuyzen Ltd: Below notifiable threshold → 7.53% / 8,000,000.

MoreLess · ENSI Holding notification

Holding(s) in Company
· 07:00

Shareholder
Esterhuyzen Ltd
Previous position
Below notifiable threshold
New position
7.53% / 8,000,000
Context
New major holding.
ENSIEnSilica

Retail offer result and meeting notice

Retail offer completed; fundraising moved to shareholder approval.

MoreLess · ENSI Retail offer result and meeting notice

Result of Retail Offer & Notice of GM
· 07:00

Announcement
Retail offer completed; fundraising moved to shareholder approval.
ENSIEnSilica

Holdings after fundraising

First fundraising tranche diluted existing major holders; revised holdings disclosed.

MoreLess · ENSI Holdings after fundraising

Holdings in Company
· 12:55

Ian Lankshear
16,040,358 / 15.10%
Richard Ashley Hamer
5,857,490 / 5.51%
Marc Castells
5,746,554 / 5.41%
Richard Neil Marley
4,771,554 / 4.49%
Other disclosed holders
Wong 3.20%; Maund 3.12%; Wheeler 2.81%; Faulkner 2.51%; Weiner 2.37%
IGPIntercede

FY26 revenue and EBITDA below expectations

Revenue expected 8–9% below market expectations. Adjusted EBITDA 15–18% below.

FY27 revenue target of £21m maintained.

MoreLess · IGP FY26 revenue and EBITDA below expectations

Year End Trading Update
· 07:00

Figure
Revenue 8-9% below expectations
Figure
Adj EBITDA 15-18% below
Figure
Cash 3-5% ahead
Figure
FY27 revenue target £21m
IHCInspiration Healthcare

Holding notification

Redworth Portfolio Ltd holding 23.079% → 25.03%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 09:33

Shareholder
Redworth Portfolio Ltd
Previous position
23.079%
New position
25.03%
Shares/voting rights
22,443,237 shares
Threshold crossed
13 March 2026
TRTTransense Technologies

Ryan Maughan buys 14,113 shares

Ryan Maughan bought 14,113 shares at 70.8p (£9,992.00).

MoreLess · TRT Ryan Maughan buys 14,113 shares

Director/PDMR Shareholding - acquisition of shares
· 11:12

Person
Ryan Maughan
Role
Managing Director
Transaction
Purchase of 14,113 shares
Price
70.8p
Gross value
£9,992.00Calculated
Resulting holding
106,154 shares / 0.70%
ENSIEnSilica

Retail offer launched for up to £0.3m

Retail shareholders offered up to £0.3m of shares on the placing terms.

MoreLess · ENSI Retail offer launched for up to £0.3m

Retail Offer to raise up to £0.3 million
· 07:01

Figure
Up to £0.3m
Figure
47p issue price
TRTTransense Technologies

Cummins project adds approximately £0.6m of funded work

Cummins-backed electric-drivetrain sensor project adds c.£0.6m of funded work.

MoreLess · TRT Cummins project adds approximately £0.6m of funded work

Award of major APC-backed project with Cummins
· 07:00

Figure
c.£0.6m project value
ENSIEnSilica

£9.7m raised at 47p

£9.7m gross at 47p per share, before the retail offer.

New shares approximately 17.6% of the pre-raise share count.

MoreLess · ENSI £9.7m raised at 47p

Result of oversubscribed Placing and Subscription
· 07:00

Figure
£9.7m gross
Figure
47p issue price
New shares / existing shares
c.17.6% of the pre-raise share count, before the retail offer.Calculated
ENSIEnSilica

Equity raise of up to £10m proposed at 47p

Up to £10m equity raise proposed at 47p to fund growth and working capital.

MoreLess · ENSI Equity raise of up to £10m proposed at 47p

Proposed equity fundraising via ABB
· 16:35

Figure
Up to c.£10m gross
Figure
47p issue price
ENSIEnSilica

Design wins & programme upgrades

New contracts and programme expansions announced.

MoreLess · ENSI Design wins & programme upgrades

New Contract Wins and Programme Upgrades
· 07:00

Announcement
New design wins and programme expansions increased funded development work.
IHCInspiration Healthcare

Four-year NHS framework renewed

Neonatal respiratory products retained on a four-year NHS England and Wales framework.

Revenue value and minimum commitments not disclosed.

MoreLess · IHC Four-year NHS framework renewed

UK neonatal division wins NHS framework agreement
· 07:00

Figure
4-year framework
Figure
Value not disclosed
SPRSpringfield Properties

Director dealing

Chairman transferred 400,000 shares at nil cost to a family member; disclosed interest remained 21.0%.

MoreLess · SPR Director dealing

Director/PDMR Shareholding
· 14:18

Person
Sandy Adam, Chairman
Transaction
Nil-consideration family transfer
Shares
400,000
Consideration
Nil
Recipient
Partner of one of his sons
Resulting interest
25,040,120 shares / 21.0%
ENSIEnSilica

Satellite communications update

UK government satellite communications announcement.

MoreLess · ENSI Satellite communications update

UK Gov Furthers Investment in Satellite Comms
· 12:50

Announcement
UK government satellite communications announcement.
SPRSpringfield Properties

Voting rights

373 option-exercise shares issued; voting rights increased to 119,147,819.

MoreLess · SPR Voting rights

Total Voting Rights
· 16:29

New shares issued
373
Reason
Employee option exercises
Issued shares / voting rights
119,147,819
Treasury shares
Nil
HERCHerculesFormer holding

Advantage NRG secures another £6.7m of work

A further £6.7m lifts disclosed Advantage NRG 2026 work to £13.2m.

MoreLess · HERC Advantage NRG secures another £6.7m of work

Advantage NRG secures £6.7m of contracted works
· 07:00

Figure
£6.7m new work
Figure
£13.2m cumulative disclosed work
Figure
Up to 79 operatives
IHCInspiration Healthcare

Holding notification

Redworth Portfolio Ltd holding 22.520% → 23.079%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 09:23

Shareholder
Redworth Portfolio Ltd
Previous position
22.520%
New position
23.079%
Shares/voting rights
20,693,237 shares
Threshold crossed
24 February 2026
SPRSpringfield Properties

Share scheme return

105,041 scheme shares issued during the six months; closing unallotted balances disclosed across four plans.

MoreLess · SPR Share scheme return

Block Listing Six Monthly Return
· 09:06

Shares issued under schemes
105,041 totalCalculated
CSOP issued
73,777
Employee plan issued
3,397
Performance plan issued
27,867
Closing unallotted balances
SAYE 101,164; CSOP 591,291; employee plan 1,801,647; performance plan 34,049
Shares in issue
119,147,446
ENSIEnSilica

Holding notification

Richard Neil Marley: 5.92% → 4.94% / 4,771,554.

MoreLess · ENSI Holding notification

Holding(s) in Company
· 17:02

Shareholder
Richard Neil Marley
Previous position
5.92%
New position
4.94% / 4,771,554
Context
Position fell below 5%.
TRTTransense Technologies

H1 results

PBT approximately £0.55m. Net cash approximately £0.9m.

January’s revised FY26 expectations unchanged.

MoreLess · TRT H1 results

Interim Results
· 07:00

Figure
PBT c.£0.55m
Figure
Net cash c.£0.9m
SPRSpringfield Properties

H1 results

Net bank debt £39.6m, down 37%.

Gross margin and private housing completions lower.

MoreLess · SPR H1 results

Interim Results
· 07:00

Figure
Revenue £108.0m (+2%)
Figure
Adj PBT £4.1m (+8%)
Figure
Net debt £39.6m (-37%)
Figure
Gross margin 15.8%
IHCInspiration Healthcare

FY26 revenue slightly ahead of expectations

FY26 revenue moved slightly ahead of consensus; net debt fell 39% to £5.1m.

MoreLess · IHC FY26 revenue slightly ahead of expectations

Full year trading update
· 07:00

Figure
Revenue £47.5m (+24%)
Figure
Adj EBITDA c.£2.8m
Figure
Net debt £5.1m (-39%)
TRTTransense Technologies

Holding notification

Dowgate Group: 11.53% → 10.872967% / 1,654,853 shares.

MoreLess · TRT Holding notification

Holding(s) in Company
· 10:22

Shareholder
Dowgate Group
Previous position
11.53%
New position
10.872967% / 1,654,853 shares
IHCInspiration Healthcare

Holding notification

Redworth Portfolio Ltd holding 21.49% → 22.52%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 09:05

Shareholder
Redworth Portfolio Ltd
Previous position
21.49%
New position
22.52%
Shares/voting rights
20,193,237 shares
Threshold crossed
6 February 2026
HERCHerculesFormer holding

FY25 results update

FY25 revenue ahead of prior expectations.

Exceptional and non-underlying costs reduce statutory profit.

MoreLess · HERC FY25 results update

Update on Final Results
· 08:22

Figure
Revenue c.£121m
Figure
Reported PBT c.£0.8m
TRTTransense Technologies

Holding notification

Dowgate Group: 12.52% → 11.53% / 1,754,853 shares.

MoreLess · TRT Holding notification

Holding(s) in Company
· 16:49

Shareholder
Dowgate Group
Previous position
12.52%
New position
11.53% / 1,754,853 shares
IGPIntercede

Holding notification

William Christopherson disclosed a new 3.025% holding.

MoreLess · IGP Holding notification

Holding(s) in Company
· 12:55

Shareholder
William John Clifford Christopherson
New position
1,820,000 shares / 3.025138%
Threshold crossed
5 February 2026
ENSIEnSilica

Siemens programme reaches production milestone

Siemens programme reached a production milestone.

MoreLess · ENSI Siemens programme reaches production milestone

Production Milestone Achieved on Siemens Contract
· 07:00

Announcement
Siemens programme reached a production milestone.
IHCInspiration Healthcare

Cavendish appointed joint broker

Cavendish appointed joint broker alongside Panmure Liberum.

MoreLess · IHC Cavendish appointed joint broker

Appointment of Joint Broker
· 07:00

New joint broker
Cavendish Capital Markets
Effective
3 February 2026
Existing adviser/broker
Panmure Liberum
ENSIEnSilica

H1 FY26 results

Results confirmed the trading update. Operating cash flow improved by £6.0m.

MoreLess · ENSI H1 FY26 results

Half-year Financial Report
· 07:00

Figure
Revenue £12.7m (+37%)
Figure
Operating cash flow £4.4m
Figure
Investment £3.1m
Figure
Cash £2.0m
TRTTransense Technologies

Holding notification

Dowgate Group: 13.91% → 12.52% / 1,904,853 shares.

MoreLess · TRT Holding notification

Holding(s) in Company
· 12:36

Shareholder
Dowgate Group
Previous position
13.91%
New position
12.52% / 1,904,853 shares
IHCInspiration Healthcare

Holding notification

Redworth Portfolio Ltd holding 20.023% → 21.49%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 11:01

Shareholder
Redworth Portfolio Ltd
Previous position
20.023%
New position
21.49%
Shares/voting rights
19,268,237 shares
Threshold crossed
30 January 2026
HERCHerculesFormer holding

Advantage NRG secures £6.5m of work

£6.5m of 2026 contracted work secured for Advantage NRG.

MoreLess · HERC Advantage NRG secures £6.5m of work

Advantage NRG secures £6.5m of contracted works
· 07:00

Figure
£6.5m contracted work
Figure
Up to 52 operatives
Figure
Jan-Dec 2026
TRTTransense Technologies

FY26 revenue and profit below expectations

Revenue expected at least £5.2m, approximately 20% below consensus.

Profit materially below expectations.

MoreLess · TRT FY26 revenue and profit below expectations

Trading update and notice of interim results
· 07:00

Figure
Revenue at least £5.2m
Figure
c.20% below consensus
Figure
Cash c.£0.92m
IHCInspiration Healthcare

Holding notification

Redworth Portfolio Ltd holding 19.688% → 20.023%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 13:40

Shareholder
Redworth Portfolio Ltd
Previous position
19.688%
New position
20.023%
Shares/voting rights
17,953,302 shares
Threshold crossed
27 January 2026
IHCInspiration Healthcare

US agreement includes an initial 150 ventilators

Three-year US agreement adds an initial 150 ventilators plus recurring consumables and service.

MoreLess · IHC US agreement includes an initial 150 ventilators

Purchasing agreement in the US
· 07:00

Figure
3-year term
Figure
150 ventilators initially
Figure
Contract value not disclosed
IHCInspiration Healthcare

Holding notification

Redworth Portfolio Ltd holding 16.577% → 19.688%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 09:46

Shareholder
Redworth Portfolio Ltd
Previous position
16.577%
New position
19.688%
Shares/voting rights
17,653,302 shares
Threshold crossed
26 January 2026
SPRSpringfield Properties

Interim results due 17 February

Interim results scheduled for 17 February 2026.

MoreLess · SPR Interim results due 17 February

Notice of Results
· 07:00

Reporting period
Six months ended 30 November 2025
Results date
17 February 2026
Shareholder webinar
18 February 2026 at 09:00 GMT
IHCInspiration Healthcare

Holding notification

Redworth Portfolio Ltd holding 15.016% → 16.577%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 10:02

Shareholder
Redworth Portfolio Ltd
Previous position
15.016%
New position
16.577%
Shares/voting rights
14,863,562 shares
Threshold crossed
23 January 2026
IHCInspiration Healthcare

Holding notification

Universal Investment GmbH disclosed 0% from 6.12%.

MoreLess · IHC Holding notification

Holding(s) in Company
· 13:37

Shareholder
Universal Investment GmbH
Previous position
6.12% / 4,161,500 shares
New position
0% / nil shares
ENSIEnSilica

H1 results due 3 February

H1 FY26 results scheduled for 3 February; investor presentation on 5 February.

MoreLess · ENSI H1 results due 3 February

Notice of Results & Investor Presentation
· 07:00

Reporting period
Six months ended 30 November 2025
Results date
3 February 2026
Investor presentation
5 February 2026 at 12:00 GMT
HERCHerculesFormer holding

Preferred supplier appointment

Added to a preferred supplier list for infrastructure labour.

MoreLess · HERC Preferred supplier appointment

Hercules added to Preferred Supplier List
· 07:01

Announcement
Preferred-supplier status for infrastructure labour.
HERCHerculesFormer holding

FY25 accounts delayed while audit continues

FY25 results publication delayed while audit work continued.

MoreLess · HERC FY25 accounts delayed while audit continues

Update on release of Final Results
· 07:00

Announcement
FY25 results publication delayed while audit work continued.
IGPIntercede

200,000 employee options exercised

200,000 employee options exercised; voting rights increased to 60,162,546.

MoreLess · IGP 200,000 employee options exercised

Exercise of Options & Total Voting Rights
· 10:44

Options exercised
200,000
Exercise price
Not disclosed
Expected admission
22 January 2026
Issued shares
60,536,452
Treasury shares
373,906
Voting rights
60,162,546
SPRSpringfield Properties

CEO sells 100,000 shares

CEO Innes Smith sold 100,000 shares at 132.5p (£132,500); holding fell to 0.8%.

MoreLess · SPR CEO sells 100,000 shares

Director/PDMR Shareholding
· 07:00

Person
Innes Smith
Role
Chief Executive Officer
Transaction
Sale of 100,000 shares
Price
132.5p
Gross value
£132,500Calculated
Stated reason
Routine financial planning
Resulting holding
896,644 shares / 0.8%
ENSIEnSilica

H1 FY26 trading update

Revenue +37%. EBITDA £1.7m, up from a loss.

FY26 guidance reaffirmed.

MoreLess · ENSI H1 FY26 trading update

H1 FY 2026 Trading Update
· 07:00

Figure
Revenue c.£12.7m (+37%)
Figure
EBITDA £1.7m
Figure
Cash c.£2.0m
Figure
FY26 revenue £28-30m
SPRSpringfield Properties

Voting rights

45,476 option-exercise shares issued; voting rights increased to 119,147,446.

MoreLess · SPR Voting rights

Total Voting Rights
· 15:55

New shares issued
45,476
Reason
Employee option exercises
Issued shares / voting rights
119,147,446
Treasury shares
Nil
HERCHerculesFormer holding

CEO transfers 17.9m shares to family member

CEO transferred 17,920,845 shares to Nicola Korkmaz for nil consideration.

MoreLess · HERC CEO transfers 17.9m shares to family member

Director / PDMR Shareholding
· 12:07

Transferor
Brusk Korkmaz, CEO
Recipient
Nicola Korkmaz / Novari Holdings
Shares transferred
17,920,845
Consideration
Nil
Brusk resulting holding
17,920,846 shares / 22.5%
Nicola resulting holding
17,920,845 shares / 22.5%
About these notes

Summaries of company announcements. The original RNS is the source.

Holdings can change. HERC is a former holding; its news ends 27 AUG 26.

Journal policy →